๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India ยท Delayed Price ยท Currency is INR
2,648.00
+27.00 (1.03%)
At close: Nov 20, 2026

Glenmark Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
159,971170,426133,633126,454116,556123,049
Revenue Growth
0.00%27.53%5.68%8.49%-5.28%12.44%
Gross Profit
107,860121,02788,38380,66572,44877,568
Operating Income
27,05140,59119,06914,45711,38218,400
Net Income
14,51313,61910,471-15,0172,9729,417
Earnings Per Share
51.4148.2437.11-53.2210.5333.37
EPS Growth
43.68%30.00%---68.43%-2.93%

Revenue by Geography

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
India
37,23744,84533,96740,46143,809
North America
71,39030,17230,94331,48132,035
Europe
31,79430,06325,55620,05620,047
Latin America and Rest of The World
29,40528,13827,66623,834-
Total
169,825133,217118,131115,832123,049

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
12,90711,83616,82116,64111,68314,163
Total Debt
14,0755,93524,72712,30946,07939,620
Net Cash (Debt)
-1,1685,901-7,9064,331-34,396-25,458
Net Cash Growth
------
Net Cash Per Share
-4.1420.90-28.0215.35-121.90-90.22

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
4,06134,450-8,276-2,6546,25411,087
Capital Expenditures
-12,326-13,577-7,507-8,984-6,078-7,901
Free Cash Flow
-8,26520,873-15,783-11,638176.293,185
Free Cash Flow Growth
-----94.47%-10.64%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
67.42%71.02%66.14%63.79%62.16%63.04%
Operating Margin
16.91%23.82%14.27%11.43%9.77%14.95%
Pretax Margin
11.90%11.65%10.47%0.29%2.06%11.71%
Profit Margin
9.07%7.99%7.84%-11.88%2.55%7.65%
FCF Margin
-5.17%12.25%-11.81%-9.20%0.15%2.59%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
2.5005.0002.5002.5002.5002.500
Dividend Per Share Growth
-50.00%100.00%0%0%0%0%
Dividend Yield
0.09%0.24%0.16%0.26%0.54%0.57%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
51.5144.1741.53-44.1113.24
P/FCF Ratio
-28.82--743.8039.15
PS Ratio
4.673.533.252.141.131.01